Photodynamic therapy in breast cancer treatment
Glioblastoma (GBM) is a very aggressive and invasive brain tumor that is difficult to treat due to its genetic variation, resistance to conventional treatment, and high recurrence.
Glioblastoma (GBM) is a very aggressive and invasive brain tumor that is difficult to treat due to its genetic variation, resistance to conventional treatment, and high recurrence.
The article reviews BNCT as a promising targeted therapy for GBM, highlighting its mechanism, clinical evidence, and potential to improve survival and quality of life for patients with this highly lethal brain cancer.
Evidence level: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Related signals
- 20‑Year Risks of Breast‑Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- Breast Cancer: The good, the bad, and an important call to effective risk reduction strategies
- Clinical Trials in Cancer - Transforming Clinical Research in the United States - NCBI Bookshelf
- Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy Sequencing
- The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21st century: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors - PMC